BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katiyar A, Kaur G, Rani L, Jena L, Singh H, Kumar L, Sharma A, Kaur P, Gupta R. Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data. Sci Rep 2021;11:10957. [PMID: 34040057 DOI: 10.1038/s41598-021-90424-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Wang Y, Miettinen JJ, Kumari R, Majumder MM, Tierney C, Bazou D, Parsons A, Suvela M, Lievonen J, Silvennoinen R, Anttila P, Dowling P, O'Gorman P, Tang J, Heckman CA. S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma. Front Cell Dev Biol 2021;9:723016. [PMID: 34485305 DOI: 10.3389/fcell.2021.723016] [Reference Citation Analysis]
2 Puła A, Robak P, Mikulski D, Robak T. The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. Int J Mol Sci 2021;22:12070. [PMID: 34769503 DOI: 10.3390/ijms222112070] [Reference Citation Analysis]
3 Domenger A, Choisy C, Baron L, Mayau V, Perthame E, Deriano L, Arnulf B, Bories JC, Dadaglio G, Demangel C. The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. EMBO Mol Med 2022;:e14740. [PMID: 35014767 DOI: 10.15252/emmm.202114740] [Reference Citation Analysis]
4 Allegra A, Di Gioacchino M, Tonacci A, Petrarca C, Musolino C, Gangemi S. Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies. Cells 2021;10:2865. [PMID: 34831088 DOI: 10.3390/cells10112865] [Reference Citation Analysis]